Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Exagen Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 28 | 28 | 0 |
| Shares | 6.83M | 6.88M | +50.3K (+0.7%) |
| Value | $16.6M | $20.0M | +$3.36M (+20.2%) |
New holders (2)
Institutions that held Exagen Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BerganKDV Wealth Management, LLC | 2,500 | $7.25K | 0.00% |
| Tower Research Capital LLC (TRC) | 65 | $188 | 0.00% |
Sold out (2)
Institutions that held Exagen Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| GWM Advisors LLC | 521 | $1.27K |
| Simplex Trading, LLC | 235 | $0 |